AzTrials
AzTrials

Post-Concussion SyndromeNCT04614922

Acceptance and Commitment Therapy-based Rehabilitation of Post-concussion Symptoms

A study testing Acceptance and Commitment Therapy in people with Post-Concussion Syndrome and Post-Traumatic Headache, run by St. Olavs Hospital at 1 site in Norway.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The investigators aim to evaluate effects of an outpatient rehabilitation program based on Acceptance and Commitment Therapy compared to usual care on function in patients with post-concussion syndrome (PCS) and post-traumatic headache (PTH). Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Acceptance and Commitment Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteNorway
Study dates
29 Oct 2020to 9 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Having sustained a minimal HI or MTBI
  • PCS/ PTH had evolved within 1 week after the head trauma.
  • At least one post-concussion symptoms of at least moderate degree, that affects daily life.
  • > 6 months post-injury.
  • First line treatment has been tried, e.g. psychoeducation, increase of physical activity and pharmacological treatments for headache

Who cannot join

  • More than 5 years since last injury.
  • Symptoms are better explained by other conditions.
  • Severe communication problems, typically due to poor knowledge of Norwegian.
  • Severe psychiatric, neurological, somatic or substance abuse disorders that will make it problematic to function in a group and/or will complicate follow-up and outcome assessment.

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • St Olavs Hospital Clinic of Physical Medicine and Rehabilitation

    Trondheim

Other trials in Norway

About this study

Official title: Acceptance and Commitment Therapy-based Rehabilitation of Post-concussion Symptoms: a Randomized Controlled Trial

The investigators aim to evaluate effects of an outpatient rehabilitation program based on Acceptance and Commitment Therapy compared to usual care on function in patients with post-concussion syndrome (PCS) and post-traumatic headache (PTH). This study builds on the investigators' previous observational studies and treatment studies in this patient group.

Read the detailed description

The study is run in an outpatient setting at the Department of Physical Medicine and Rehabilitation, St. Olavs Hospital, Trondheim University Hospital, Norway. All patients are also participants in the observational study: "Minimal and mild head injury: an exercise and outpatient follow-up study at St. Olavs Hospital" (REK number 2018/2159).

Being tested
Acceptance and Commitment Therapy
Keywords
Acceptance and Commitment Therapy
Medical subject headings
Post-Concussion Syndrome, Post-Traumatic Headache

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment TherapyBehavioural

    Also called ACT

    ACT-based rehabilitation is an interdisciplinary group rehabilitation which includes 7 sessions of group-based ACT therapy. Each session lasts 2½ hours and is offered twice a week. The ACT sessions will be based on a detailed intervention manual, developed specifically for group treatment. Each group will include a maximum of eight patients. The patients are asked to do homework between each ACT-group session.

Study groups in NCT04614922
Study groupRoleWhat they receive
Acceptance and Commitment TherapyExperimentalParticipation in a 4 week group program based on Acceptance and Commitment Therapy, individual councelling and home lessions.
Receives: Behavioral: Acceptance and Commitment Therapy
control groupNo interventionStandard care, i.e. follow-up as needed, to some degree dependent on current capacity of therapists.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postcincussion symptom burden

    The Rivermead postconcussion symptom questionnaire. The scale measures 13 common postconcussion somatic, emotional and cognitive symptoms on a range from 0 (no symptoms) to 64 (all symptoms graded as severe).

    Measured: 3, 6 and 12 months after the intervention

Secondary outcomes (2)
  1. Headache

    mean change in days of headache of at least moderate intensity, based on headache diary

    Measured: 3, 6 and 12 months after the intervention

  2. Work participation

    change in the self-reported number of hours with paid work or ordinary studies per week

    Measured: 3, 6 and 12 months after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2020
  2. Study start29 Oct 2020
  3. Primary completion9 Sep 2025
  4. Study completion9 Sep 2025

Why it stopped: We could not achieve the expected number of participants within reasonable time. We decided to analyse the data with fewer participants than initially planned.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04614922
Sponsor's protocol ID
150525
Status last verified
Jul 2026
First submitted
26 Oct 2020
Last updated
21 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and Commitment Therapy in people with Post-Concussion Syndrome and Post-Traumatic Headache, run by St. Olavs Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: We could not achieve the expected number of participants within reasonable time. We decided to analyse the data with fewer participants than initially planned.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postcincussion symptom burden (time frame: 3, 6 and 12 months after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in